Investor Type | Firm |
Industries | Software (Web Marketplace Saas..) • Other • IT (& TMT) • BioTech • HealthTech (& Fitness) • Medical Devices (& Hospital Services) |
Investing | Israel |
Investment Range | $11,200,000 - $11,200,000 |
The Yozma Group is an Israeli venture capital firm that specializes in sourcing high-potential investment opportunities within a diverse set of industries. The industries they have selected to invest in include Software, which encompasses various facets like Web Marketplace, SaaS (Software as a Service), and Other categorizations that may cover niche and emerging sub-segments of the software field. Information Technology, with a focus on TMT (Technology, Media, and Telecommunications), represents another primary area of interest for the firm due to its foundational impact on modern businesses and consumer interactions. The Yozma Group also actively seeks out investments in Biotech, HealthTech, Fitness, and Medical Devices, along with Hospital Services. These sectors are known for their innovative advancements in healthcare and medical technologies, which have a significant influence on the quality of care and life-saving capabilities. The Yozma Group's investment thesis focuses on high-growth companies that are developing infrastructure and enabling technologies. This approach often leads them to pioneer investments in companies that are positioned to redefine or enhance the technological framework within their target sectors. They see value in both the disruptive potential of these businesses and their capacity to support wider industry shifts. The Yozma Group's investment range is notably specific, with both the minimum and maximum investment amount set at $11,200,000, indicating a concentrated entry strategy that could suggest a preference for more significant stakes in portfolio companies or later-stage funding rounds. This level of investment can have a transformative effect on companies within their target industries, potentially scaling operations, accelerating growth, or advancing critical research and development projects.